Clinical Trial Update: A Study of DS-9606a in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A phase 1 study of DS-9606a in patients with advanced, metastatic cancer, including germ cell tumor, was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Germ Cell Tumor

Drugs mentioned

• DS-9606a

Snippet

Sponsor: Daiichi Sankyo | Conditions: Advanced Cancer, Metastatic Cancer | Phase 1 | Status: TERMINATED